Varian, Inc.
Palo Alto, CA 94304
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Palo Alto, Calif., July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June 20, 2019. HRH Princess Maha Chakri Sirindhorn presided over the rigging ceremony. The cyclotron is a core piece of equipment of the ProBeam proton...
Read More »
Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria
PALO ALTO, Calif., July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy doses. Through the partnership, Varian made available a TrueBeam™ system to the IAEA's Dosimetry Laboratory in Seibersdorf, Austria, which will enhance...
Read More »Dissolution Apparatus supports manual and automated testing.
Designed for testing tablets, capsules, and other dosage forms, Model 708-DS features traditional water bath and TruAlign(TM) vessels. System supports several automation options, including automated media temperature sensing, dosage delivery, and sampling. Integration with Varian UV or LC Dissolution Systems accelerates sample analysis, while minimizing potential for sample handling errors.
Read More »Dissolution Apparatus facilitates drug testing.
Designed to enable testing of drug formulations with extremely low quantities of active ingredients, Model 400-DS meets compendial requirements of USP Apparatus 7. It supports testing of combinatorial products in which small amounts of drug are combined as part of medical device such as stent or implant. Available in 5 and 10 mL versions, Model 400-DS can run up to 13 samples at one time and...
Read More »SPE Products suit pharamaceutical applications.
Bond ElutÃ-® Plexa(TM) polymeric solid phase extraction products deliver streamlined sample preparation process to pharmaceutical researchers involved in clinical and preclinical studies. Polymeric design, featuring hydroxylated exterior and polarity gradient within pores, maximizes extract cleanliness and analyte recovery, resulting in optimal analytical sensitivity and data quality.
Read More »Mass Spectrometer offers femtogram detection limits.
Model 320-MS triple quadrupole mass spectrometer is capable of femtogram detection limits and mass range up to 2,000 da to identify wide range of compounds. With design that enables switching between liquid chromatography and gas chromatography formats, unit occupies less than 72 cm of linear bench space and is offered with MS Workstation software v6.8, HPLC pumps and detectors, industry standard...
Read More »NMR Spectrometer suits small analytical laboratories.
Designed for molecular characterization and quantization, Model 400-MR magnetic resonance spectrometer offers compact footprint for use in pharmaceutical, biotech, chemical, and academic laboratories. NMR system features workstation software with local language support capability to provide data processing and acquisition tools. Spectrometer offers detection and quantification of minor components...
Read More »Vacuum Pumps target high throughput applications.
Enabling incorporation of smaller pumps into system designs, Turbo-V 81 series vacuum pumps increase instrument sensitivity in application areas that demand high vacuum integrity such as mass spectrometry, electron microscopy, and high energy physics. Model Turbo-V 81-T offers high speed with low power consumption in compact design, while Model Turbo-V 81-M featuring MacroTorrÃ-® stages, is...
Read More »Drug Testing Kit offers low detection limits for parent-THC.
Used for simultaneous screening of amphetamine, opiates, cocaine, PCP, methamphetamine, and THC drugs, OnSiteÃ-® OraLabÃ-® oral fluid drug testing device is used for pre-employment, random, reasonable suspicion, and post-accident testing, as well as for court-mandated compliance. Expresser and single tube design allow collection and storage of saliva for immediate screening and...
Read More »HPLC Columns target preparative R&D applications.
Specifically designed for benchtop preparative liquid chromatography applications, PursuitÃ-® XRs Prep Columns combine high ligand density with 5 and 10 micron, 100 angstrom silica. They provide high-resolution separations, while allowing highest available mass loading. Available in C18 and silica phases, columns are formulated for use in pharmaceutical, biotech, and natural product...
Read More »Varian Establishes Direct Operation in Kenya
PALO ALTO, California and NAIROBI, Kenya, Nov. 26, 2019 /PRNewswire/ -- At a grand opening ceremony attended by local dignitaries (H.E. Governor Prof. Anyan'g Nyong'o – Governor of Kisumu County, Vice Chairman – CoG Health Committee; Hon. Dr. Swarup Mishra Kiprop Arap Chelulei – MP – Kesses, Group Chairman, Founder Mediheal Hospitals, Vice Chairman - Parliament Health Committee;...
Read More »Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
Palo Alto, Calif., Nov. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian was ranked number three in the Healthcare Equipment and Services Industry and number 39 on this year's overall list for outperforming its peers in...
Read More »Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Ca
PALO ALTO, Calif., Nov. 6, 2019 /PRNewswire/ -- In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support its efforts to develop patient-centered quality measures for cancer care. This year, there were an estimated 58,000 new cancer cases in the state of...
Read More »Varian Names Anshul Maheshwari Vice President Investor Relations
Palo Alto, Calif., Oct. 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries should be directed to Mr. Maheshwari. Prior to joining Varian in July 2018, Mr. Maheshwari was the assistant treasurer of Bechtel Corporation, where he had...
Read More »Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components
PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019. We are thankful for the USTR and U.S. government's continued recognition of the...
Read More »Varian Ranked Highest in Survey of US Radiation Oncology Professionals
PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally, Varian's Net Promotor Score improved from 71 in 2018 to 78 in 2019, and again was the highest among industry competitors. Net Promotor Scores represents the...
Read More »Varian Announces Immaterial Impact of Newly Proposed Tariffs
PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion in Chinese imports beginning September 1, 2019. Varian estimates these newly proposed...
Read More »
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Palo Alto, Calif., July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June 20, 2019. HRH Princess Maha Chakri Sirindhorn presided over the rigging ceremony. The cyclotron is a core piece of equipment of the ProBeam proton...
Read More »
Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria
PALO ALTO, Calif., July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy doses. Through the partnership, Varian made available a TrueBeam™ system to the IAEA's Dosimetry Laboratory in Seibersdorf, Austria, which will enhance...
Read More »Varian to Provide Mobile Technology to Cancer Patients Across Tennessee
PALO ALTO, Calif., June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased participation in their treatment, Varian (NYSE: VAR) today announced its collaboration with Tennessee Oncology for the implementation of Noona®, a software application for managing patient symptoms and capturing patient reported outcomes (PROs) in cancer care. As part of this collaboration,...
Read More »